Notice of Correction to Title for RFA-CA-18-004 "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)"

Notice Number: NOT-CA-18-025

Key Dates
Release Date: November 30, 2017

Related Announcements
RFA-CA-18-004

Issued by
National Cancer Institute (NCI)

Purpose

This Notice corrects the Title of RFA-CA-18-004 "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)".

Part 1. Overview Information

Funding Opportunity Title

Currently reads:

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

Should correctly read:

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Tony Dickherber, Ph.D. 
National Cancer Institute (NCI)
Telephone: 301-547-9980 
Email: dickherberaj@mail.nih.gov

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov